TRDA
Entrada Therapeutics Inc
NASDAQ: TRDA · HEALTHCARE · BIOTECHNOLOGY
$14.50
+7.41% today
Updated 2026-05-01
Market cap
$503.12M
P/E ratio
—
P/S ratio
19.79x
EPS (TTM)
$-3.47
Dividend yield
—
52W range
$5 – $14
Volume
0.2M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
3.3
Growth
D8.0
Quality
A2.5
Profitability
F5.0
Valuation
C+2/9
Piotroski F-Score
Weak
2.4
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$21.40
+47.59%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.15x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-32.41M
- Revenue declining -96.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $25.26M | $129.01M | $210.78M | $25.42M | $25.42M |
| Net income | $-87.46M | $-6.68M | $65.63M | $-143.75M | $-39.16M |
| EPS | — | — | — | — | $-3.47 |
| Free cash flow | $-96.67M | $134.19M | $-44.72M | $-129.55M | $-32.41M |
| Profit margin | -346.23% | -5.18% | 31.13% | -565.48% | — |
Peer comparison
Smart narrative
Entrada Therapeutics Inc trades at $14.50. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 2.36, it sits in the grey zone. TTM revenue stands at $25.42M.
Frequently asked questions
What is Entrada Therapeutics Inc's stock price?
Entrada Therapeutics Inc (TRDA) trades at $14.50.
Is Entrada Therapeutics Inc overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell).
What is the price target of Entrada Therapeutics Inc (TRDA)?
The analyst target price is $21.40, representing +47.6% upside from the current price of $14.50.
What is Entrada Therapeutics Inc's revenue?
TTM revenue is $25.42M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
2.36 — grey zone.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio19.79x
ROE-39.10%
Beta-0.15
50D MA$12.57
200D MA$9.03
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week+6.89%
1 month+0.15%
3 months+18.01%
YTD+31.32%
1 year—
3 years—
5 years—